Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-045408
Filing Date
2011-02-24
Accepted
2011-02-24 16:33:00
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2851001
2 AMENDED AND RESTATED PRIME VENDOR AGREEMENT dex1040.htm EX-10.40 130168
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1669
4 CONSENT OF KPMG LLP dex231.htm EX-23.1 1842
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex232.htm EX-23.2 1350
6 302 CERTIFICATION OF THE CEO dex311.htm EX-31.1 6053
7 302 CERTIFICATION OF THE CFO dex312.htm EX-31.2 6268
8 906 CERTIFICATION OF THE CEO dex321.htm EX-32.1 2849
9 906 CERTIFICATION OF THE CFO dex322.htm EX-32.2 2881
10 GRAPHIC g153276g01q91.jpg GRAPHIC 52004
  Complete submission text file 0001193125-11-045408.txt   3077368
Mailing Address 1901 CAMPUS PLACE LOUISVILLE KY 40299
Business Address 1901 CAMPUS PLACE LOUISVILLE KY 40299 502.627.7000
PharMerica CORP (Filer) CIK: 0001388195 (see all company filings)

EIN.: 870792558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33380 | Film No.: 11636720
SIC: 5912 Retail-Drug Stores and Proprietary Stores